NEW

NDTV िह몭ी BUSINESS MOVIES CRICKET TECH FOOD CRYPTO WEB STORIES EDUCATION AUTO SWASTH LIFESTYLE HEALTH SHOPPING ART

LIVE TV LATEST COVID-19 INDIA VIDEO OPINION WORLD CITIES OFFBEAT TRENDS PHOTOS

Home All India This Company Will Produce Pharma Firm Cadila's 3-Dose COVID-19 Vaccine 'ZyCov-D' Advertisement

This Company Will Produce Pharma Firm

Advertisement

Cadila's 3-Dose COVID-19 Vaccine 'ZyCov-D'

ZyCov-D Vaccine: Cadila, which is expected to begin supplying its vaccine from next month, aims to
make 100 million to 120 million doses of ZyCoV-D a year.
Advertisement
All India Reuters Updated: September 24, 2021 4:50 pm IST

TRENDING

Ratan Tata's Shout-

Out For Taj Employee
Who Shared Umbrella
With Stray Dog
QUICK LINKS
Coronavirus News IPL 2021

Dream To Join IAS IPL 2021 Points Table Latest News

And Serve
Underprivileged Live Train status PNR Status Covaxin
Realised: UPSC
World News Weather News Hindi News
Topper
Raazi Full Movie Redbus offers

Nykaa Coupon Codes Microtek Inverter

US President Jokes
About "5 Bidens In Advertisement
India", PM Modi
"Offers" Papers
Coronavirus Vaccine ZyCov-D will be made by Shilpa Medicare and Cadila will distribute the shot (File)

Food
Unique Keema
Samosa Recipe
12 Slides
Bengaluru: Drugmaker Shilpa Medicare Limited said on Friday it had agreed to
produce Cadila Healthcare Ltd's three-dose COVID-19 vaccine.
Celeb
Kajol's Love For The country's health authorities had given emergency approval in August for
Sarees
10 Slides
Cadila's vaccine, the world's 몭rst COVID-19 DNA shot, in adults and children aged
12 years and above.

Wellness Cadila, which is expected to begin supplying its vaccine from next month, aims to
The Many Health
make 100 million to 120 million doses of ZyCoV-D a year.
Bene몭ts Of Moringa
14 Slides

While India's vaccination programme aims to inoculate all eligible adults by

December, the country also expects to resume exports to meet its commitments
under the global COVAX initiative from October to December.

Shilpa Medicare said its unit will make the vaccine's drug substance, while Cadila
will package, distribute and market the shot.

The targeted production of the ZyCoV-D vaccine from Shilpa Medicare's facility in
Karnataka has not been disclosed. Cadila and Shilpa Medicare did not
immediately respond to Reuters requests seeking details on the deal.

A government source told Reuters last week that Cadila Healthcare will supply 10
million doses of its COVID-19 vaccine in October.
 Shilpa Medicare also produces the Russian Sputnik V vaccine under an
agreement with Indian pharma giant Dr. Reddy's Laboratories.

Shares of Shilpa Medicare, which rose about 2% after the announcement, were
last down about 0.6%. Cadila Healthcare's shares were unchanged.

Track Latest News Live on NDTV.com and get news updates from India and
around the world. Shilpa Medicare Limited,
Cadila Healthcare,
ZyCov-D
WATCH LIVE NEWS: FOLLOW US:

LATEST NEWS

29,616 Fresh COVID-19 "Important Period In Prince Andrew Accepts PM Modi Raises Issue PM Modi Invites US
Cases In India, 5.6% India's Journey": PM To He Has Been Served In Of Indians In US, H-1B President Joe Biden To
Lower Than Yesterday Successful UPSC US Sex Case Visas With Biden: Visit India
Candidates Government

About Us Advertise News Alert Archives Apps Careers Channels Disclaimer Feedback Investors Ombudsman Redressals Service Terms

this website follows the dnpa code of ethics © copyright ndtv convergence limited 2021. all rights reserved.